These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16302425)

  • 1. [Ray of hope for therapy of severe allergic asthma: blockade of IgE closes the treatment gap].
    MMW Fortschr Med; 2005 Oct; 147(43):52-3. PubMed ID: 16302425
    [No Abstract]   [Full Text] [Related]  

  • 2. [First antibody against IgE in view. Hope for severely ill asthmatic patients ].
    Buhl R
    MMW Fortschr Med; 2005 Sep; 147(39):56. PubMed ID: 16245785
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.
    Busse WW; Massanari M; Kianifard F; Geba GP
    Curr Med Res Opin; 2007 Oct; 23(10):2379-86. PubMed ID: 17711616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of omalizumab in children with allergic (IgE-mediated) asthma.
    Milgrom H; Fowler-Taylor A; Vidaurre CF; Jayawardene S
    Curr Med Res Opin; 2011 Jan; 27(1):163-9. PubMed ID: 21121874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-IGE therapy in asthma].
    Mehiri Ben Rhouma N; Béji M; Louzir B; Daghfous J
    Tunis Med; 2002 Oct; 80(10):575-80. PubMed ID: 12632749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab (Xolair): an anti-IgE antibody for asthma.
    Med Lett Drugs Ther; 2003 Aug; 45(1163):67-8. PubMed ID: 12915804
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of older patients with IgE-mediated asthma to omalizumab: a pooled analysis.
    Maykut RJ; Kianifard F; Geba GP
    J Asthma; 2008 Apr; 45(3):173-81. PubMed ID: 18415822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgE in severe persistent allergic asthma.
    Fox H
    Respirology; 2007 Nov; 12 Suppl 3():S22-8; discussion S45-7. PubMed ID: 17956516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L; Sorkness CA
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab for pediatric asthma.
    Townley RG; Agrawal S; Sapkota K
    Expert Opin Biol Ther; 2010 Nov; 10(11):1595-608. PubMed ID: 20955114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G
    Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
    Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A; Sternon J
    J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pratical aspects of anti-Ige therapy in severe allergic asthma].
    Taramarcaz P; Hauser C; Rochat T
    Rev Med Suisse; 2007 Apr; 3(108):1050-2, 1054-5. PubMed ID: 17552257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IgE therapy in children with asthma.
    Milgrom H
    Minerva Pediatr; 2004 Oct; 56(5):469-79. PubMed ID: 15459572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab in the treatment of severe asthma: efficacy and current problems.
    Pelaia G; Renda T; Romeo P; Busceti MT; Maselli R
    Ther Adv Respir Dis; 2008 Dec; 2(6):409-21. PubMed ID: 19124386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection.
    Cruz AA; Lima F; Sarinho E; Ayre G; Martin C; Fox H; Cooper PJ
    Clin Exp Allergy; 2007 Feb; 37(2):197-207. PubMed ID: 17250692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home therapy with subcutaneous anti-immunoglobulin-E antibody omalizumab in 25 patients with immunoglobulin-E-mediated (allergic) asthma.
    Liebhaber M; Dyer Z
    J Asthma; 2007 Apr; 44(3):195-6. PubMed ID: 17454337
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.